Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Genetics (3)
Oncogene (2)
Blood Cancer Journal (2)
Leukemia (1)
Acta Pharmacologica Sinica (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (9)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Drug discovery
Genetics
Medical research
Molecular biology
Nephrology
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–10 of 10 results

Advanced filters: Author: Kai Neben Clear advanced filters

Acetamide-45 inhibited hyperresponsiveness and airway inflammation in mice partly depending on phosphodiesterase activity suppression

Kai Wang
Hua-hao Shen
Zhong Chen
Research01 Oct 2008
Acta Pharmacologica Sinica

Volume: 29, P: 1195-1201
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of end-stage renal disease with limited treatment options. Here the authors discover and characterize a microRNA inhibitor as a potential treatment for ADPKD.

Edmund C. Lee
Tania Valencia
Vishal Patel
ResearchOpen Access12 Sept 2019
Nature Communications

Volume: 10, P: 1-14
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma

Richard Houlston, Kari Hemminki and colleagues report a meta-analysis of genome-wide association studies of multiple myeloma and identify a variant in the CCDN1 gene that influences risk for developing a specific tumor karyotype with the t(11;14)(q13;q32) translocation.

Niels Weinhold
David C Johnson
Kari Hemminki
Research17 Mar 2013
Nature Genetics

Volume: 45, P: 522-525
Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes

Kai Neben
Björn Tews
Peter Lichter
Research09 Feb 2004
Oncogene

Volume: 23, P: 2379-2384
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

Richard Houlston, Gareth Morgan, Kari Hemminki and colleagues report the results of a genome-wide association study of multiple myeloma. They identify two regions influencing susceptibility to this hematological malignancy.

Peter Broderick
Daniel Chubb
Richard S Houlston
Research27 Nov 2011
Nature Genetics

Volume: 44, P: 58-61
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

Richard Houlston and colleagues report a genome-wide association study of multiple myeloma and identify four loci associated with susceptibility to this malignancy.

Daniel Chubb
Niels Weinhold
Hartmut Goldschmidt
Research18 Aug 2013
Nature Genetics

Volume: 45, P: 1221-1225
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Elias K. Mai
Thomas Hielscher
Hartmut Goldschmidt
Research29 Jun 2018
Leukemia

Volume: 33, P: 258-261
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

Marc-Andrea Baertsch
Elias K. Mai
Hartmut Goldschmidt
ResearchOpen Access07 Jan 2021
Blood Cancer Journal

Volume: 11, P: 1-10
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype

Kai Neben
Susanne Schnittger
Claudia Schoch
Research10 Jan 2005
Oncogene

Volume: 24, P: 1580-1588
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

Maximilian Merz
Thomas Hielscher
Jens Hillengass
CorrespondenceOpen Access27 Aug 2019
Blood Cancer Journal

Volume: 9, P: 1-5